Related Experiment Video

Updated: Sep 20, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

[Development of a live culture of cold-adapted reassortant influenza vaccines]

Iu Z Gendon, S G Markushin, I I Akopova

    Voprosy Virusologii
    |August 20, 2003
    PubMed

    Insights

    Optimal conditions were determined for cultivating Madin-Darby Canine Kidney (MDCK) cells for influenza virus vaccine production. These findings enable high-titer replication of influenza A (H1N1, H3N2) and B virus strains using serum-free media.

    Area of Science:

    • Virology
    • Cell Biology
    • Biotechnology

    Context:

    • Optimizing cell culture conditions is crucial for efficient vaccine production.
    • Madin-Darby Canine Kidney (MDCK) cells are widely used for influenza virus propagation.
    • Serum-free media are increasingly preferred for large-scale cell culture to reduce costs and simplify purification.

    Purpose:

    • To establish optimal conditions for Madin-Darby Canine Kidney (MDCK) cell cultivation.
    • To evaluate the replication efficiency of influenza virus strains in MDCK cells under various conditions.
    • To determine the maximum virus titer achievable in serum-free media.

    Summary:

    • Optimal conditions for Madin-Darby Canine Kidney (MDCK) cell cultivation in laboratory spinners and monolayers were established.
    • Cold-adapted reassortant vaccine strains of influenza A (H1N1, H3N2) and B viruses replicated efficiently in MDCK cells using serum-free Eagle-MEM.
    • Maximum virus titers, dependent on multiplicity of infection and trypsin addition, reached 10(9.0)-10(9.5) EID50/ml under optimized serum-free conditions.

    Impact:

    • Provides a scalable and efficient method for producing influenza virus vaccine seed stocks.
    • Facilitates the development of cost-effective and high-yield influenza vaccines.
    • Contributes to the preparedness for influenza pandemics through improved vaccine manufacturing processes.

    More Related Videos

    Influenza A Virus Studies in a Mouse Model of Infection10:44

    Influenza A Virus Studies in a Mouse Model of Infection

    Published on: September 7, 2017

    Generation of Recombinant Influenza Virus from Plasmid DNA11:31

    Generation of Recombinant Influenza Virus from Plasmid DNA

    Published on: August 3, 2010

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    Vaccine Production01:23

    Vaccine Production

    Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
    Viral Recombination00:57

    Viral Recombination

    Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.